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O B J E C T I V E S This study sought to determine lipid and ﬁbrous volume of coronary atherosclerotic
plaques in subjects with abnormal glucose regulation (AGR) by integrated backscatter (IB) intravascular
ultrasound (IVUS) during percutaneous coronary intervention.
B A C KG ROUND Abnormal glucose regulation, including impaired glucose regulation (IGR) and
diabetes mellitus (DM), has emerged as an important determinant of cardiovascular risk. We hypothe-
sized that AGR would be associated with coronary plaque instability.
METHOD S Conventional intravascular ultrasound and IB-IVUS using a 40-MHz (motorized pullback 1
mm/s) intravascular catheter was performed in 172 consecutive patients. The percentage of ﬁbrous area and
the percentage of lipid area were automatically calculated by IB-IVUS. Three-dimensional analysis of IB-IVUS
images was performed to determine the percentage of lipid volume (%LV) and ﬁbrous volume (%FV). Following
the World Health Organization criteria, the subjects were classiﬁed into the DM group, the IGR group, and the
normal glucose regulation group. The cutoff point for the lipid-rich plaque was deﬁned as %LV44% or %FV
52%, which was the 75th percentile of %LV or the 25th percentile of %FV in this study population. Insulin
resistance (IR) was deﬁned as the homeostasis model assessment of insulin resistance (HOMA-IR).
R E S U L T S There were no signiﬁcant differences in the baseline characteristics except for glucometabolic
parameters. The conventional IVUS analysis indicated that the DM group had a signiﬁcantly increased plaque
volume (and percent plaque volume). In the IB-IVUS analysis, as compared with the normal glucose
regulation group, the DM and the IGR groups showed a signiﬁcant increase in %LV (36 14% and 37 13%
vs. 29 14%, p 0.02) and a signiﬁcant decrease in %FV (59 11% and 58 11% vs. 64 11%, p 0.03).
The lipid-rich plaque rate was signiﬁcantly associated with an increasing HOMA-IR in the tertile (p  0.008).
On logistic regression analysis after adjusting for confounding and coronary risk factors, the DM group (odds
ratio 3.52, 95% conﬁdence interval 1.13 to 11.0, p 0.03) and the IGR group (odds ratio 3.92, 95% conﬁdence
interval 1.13 to 13.6, p  0.03) were signiﬁcantly associated with the lipid-rich plaque.
CONC L U S I O N S Coronary lesions in patients with AGR are associated with more lipid-rich plaque
content, which may be related to the increased IR in these patients. (J Am Coll Cardiol Img 2008;1:
39–45) © 2008 by the American College of Cardiology Foundation
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40iabetes mellitus (DM) is a well-known risk
factor for cardiovascular disease (CVD) (1–
3). Recently, special emphasis has been given
to impaired glucose regulation (IGR) as a risk
actor in patients with as well as without frank DM
4,5). It has been proposed that macrovascular disease
tarts before the development of DM (6). Ultrasound
tudies measuring carotid intima-media thickness
ave shown the relevance of abnormal glucose regu-
ation (AGR) in subclinical atherosclerosis and in-
reased risk of CVD (7–9). Insulin resistance (IR),
which mainly accounts for AGR, has also
been shown to be related to adverse cardio-
vascular risk (10–12). We recently reported
that the metabolic syndrome, which is pre-
dominantly based on IR and the cluster of
comorbidities of AGR, is associated with
the lipid-rich plaque contributing to the
increasing risk of plaque vulnerability (13).
Insulin resistance progressively increases
when passing from normal glucose regula-
tion (NGR) through IGR to DM. Few
studies, however, have assessed the relevant
detail of AGR or IR with coronary plaque
morphology.
See page 46
In the present study, we assessed the
hypothesis that AGR would be associated
with a high content of plaque lipid (por-
tending possible plaque instability) using
the integrated backscatter (IB) intravascu-
lar ultrasound (IVUS) method to analyze
coronary tissue components (13–15).
M E T H O D S
Patients and study design. This study was a
prospectively planned observational study
for coronary lesions in patients with acute
coronary syndrome (ACS) or stable angina
ectoris who underwent percutaneous coronary inter-
ention (PCI). Intravascular ultrasound was per-
ormed before PCI in 172 consecutive patients be-
ween September 2006 and June 2007.
ardiovascular diagnoses. Acute coronary syndrome
ncluded acute myocardial infarction and unstable
ngina pectoris. The diagnosis of acute myocardial
nfarction was based on elevation of at least 1
ositive biomarker (creatine kinase, creatine kinase-
B, or troponin T), characteristic electrocardio-
s
ome
e
del
nce
al
ce
yram changes, and a history of prolonged acute mhest pain. Unstable angina pectoris was defined as
ngina with a progressive crescendo pattern or
ngina that occurred at rest.
lucometabolic parameters. Previously known DM
as defined as a diagnosis based on the World
ealth Organization classification (16). The proto-
ol recommended that all patients without previ-
usly diagnosed DM should undergo a standard
ral glucose tolerance test (OGTT, 75 g). For
cutely admitted patients, measurements of fasting
lood glucose and insulin were to be taken in stable
onditions before hospital discharge. Classification
f glucometabolic state in patients without previ-
usly diagnosed DM was then made based on
GTT in a stable condition as following:
NGR  OGTT (0 min) 110 mg/dl and
GTT (2 h) 140 mg/dl
Impaired fasting glycemia  OGTT (0 min)
110 mmol/l but 126 mg/dl and OGTT (2 h)
140 mg/dl
Impaired glucose tolerance  OGTT (0 min)
126 mg/dl and OGTT (2 h) 140 mg/dl but
200 mg/dl
DM  OGTT (0 min) 126 mg/dl or OGTT
2 h) 200 mg/dl
In the text, IGR refers to both impaired fasting
lycemia and impaired glucose tolerance. Abnormal
lucose regulation includes IGR and DM. Insulin
esistance was defined from the homeostasis model
ssessment of insulin resistance (HOMA-IR) ac-
ording to the following formula: HOMA-IR 
fasting insulin concentration (U/ml) · fasting
lucose concentration (mg/dl)/405] (17). Various
erum markers, including IR, were measured by
ommercial radioimmunoassay kits and specific im-
unoradiometric assay. For this purpose, blood
amples were collected from patients before PCI
fter a 10- to 12-h overnight fast.
eﬁnitions of analysis segments and measurements of
VUS parameters. Quantitative coronary angiogra-
hy analysis was conducted. Reference diameter
nd percentage diameter stenosis were measured by
validated automated edge-detection program
CMS-MEDIS Medical Imaging System, Leiden,
he Netherlands). Coronary lesions included the
roximal and distal sites of the target lesions for
CI. The mean length of the analyzed segment
as 37 mm (37 IB-IVUS images) per patient.
evere coronary lesions that could not be crossed
y the IVUS catheter were excluded. Conventional
-dimensional (2D) images were quantified for
umen cross-sectional area (LCSA), external elasticB B R E V I A T I O N S
N D A C R O N YM S
FV percentage of fibrou
olume
LV percentage of lipid
olume
CS acute coronary syndr
GR abnormal glucose
egulation
SA cross-sectional area
VD cardiovascular diseas
M diabetes mellitus
EM external elastic
embrane
OMA-IR homeostasis mo
ssessment of insulin resista
B-IVUS integrated
ackscatter intravascular
ltrasound
GR impaired glucose
egulation
R insulin resistance
CSA lumen cross-section
rea
GR normal glucose
egulation
GTT oral glucose toleran
est
CI percutaneous coronarembrane (EEM), cross-sectional area (CSA), and
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41laque (P)  media (M) CSA (P  M CSA 
EM CSA  LCSA) using the software of the
VUS system. An eccentricity index of P  M was
alculated by the formula of (maximum P  M
hicknessminimum PM thickness)/maximum
 M thickness. A remodeling index was defined
s a ratio of EEM CSA at the measured lesion
minimum luminal site) to reference EEM CSA
average of the proximal and distal reference seg-
ents). The 2D analysis referred to the segment
ith minimal luminal area. Three-dimensional
3D) analysis for conventional IVUS images was
erformed to compute vessel volume, lumen vol-
me, and plaque volume (sum of EEM CSA,
CSA, and PM CSA at 1-mm axial intervals for
he analysis segments). The IB-IVUS analysis was
erformed as previously reported (13–15). In brief,
personal computer equipped with custom software
IB-IVUS, YD Co., Nara, Japan) was connected to
he IVUS imaging system (Clear View, Boston
cientific, Natick, Massachusetts) to obtain radio-
requency signal trigger output. Ultrasound back-
cattered signals were acquired using a 40-MHz
motorized pullback 1 mm/s) mechanically rotating
VUS catheter, to be digitized and subjected to
pectral analysis. Integrated backscatter values for
ach tissue component were calculated as an average
ower using a fast Fourier transform, measured in
ecibels, of the frequency component of backscat-
ered signal from a small volume of tissue (13–15).
he percentage of fibrous area (fibrous area/plaque
rea, %FA) and the percentage of lipid area (lipid
rea/plaque area, %LA) were automatically calcu-
ated by the IB-IVUS system (using commercially
vailable software). The percentage of high signal
rea (a part of the calcification on the inner surface
hat could be measured with the formula of IB-
VUS/plaque area) was also calculated. The 3D
nalysis for IB-IVUS images was performed for
brous volume, lipid volume, and high signal vol-
me (sum of fibrous, lipid, and high signal area in
ach CSA at 1-mm axis intervals for the average of
7 IB-IVUS images per patient, respectively). Then
he percentage of fibrous volume (fibrous volume/
laque volume, %FV), lipid volume (lipid volume/
laque volume, %LV) and high signal volume were
alculated. The quantitative coronary angiography
nd IVUS measurements were conducted indepen-
ently by 2 physicians who were blinded to the
atient’s clinical characteristics. The variability on
LV and %FV determined by 2 physicians wasonsidered from 50 randomly selected records.tatistical analyses. Statistical analysis was per-
ormed using the SAS statistical software package
version 8.02, SAS Institute Inc., Cary, North
arolina). Continuous and categorical variables
ere expressed as mean  standard deviation and
roportions, respectively. Comparisons of various
linical and IVUS parameters among the 3 groups
ere evaluated using analysis of variance, and a
onferroni test was performed for multiple com-
arisons. We defined the cutoff point for the
ipid-rich plaque as %LV 44% or %FV 52%,
hich was the 75th percentile of %LV or 25th
ercentile of %FV in the present study population
13,18). Following this definition, multivariate lo-
istic regression analysis was applied to study the
redictors of the lipid-rich plaque by adjusting for
redefined variables. All variables with a p value
Table 1. Baseline Clinical Characteristics
NGR
(n  38)
IGR
(n  44) (n
Male 24 (63) 33 (77) 5
Age, yrs 68  9 69  10 6
Clinical history
Hypertension 26 (68) 30 (68) 5
Current smoker 10 (26) 10 (23) 2
Coronary artery disease
Acute coronary syndrome 10 (26) 13 (30) 1
Old myocardial infarction 6 (16) 12 (27) 2
Multiple vessel 19 (50) 23 (52) 5
Ejection fraction, % 68  13 65  12 6
Fasting blood sugar, mg/dl 91  11 114  20† 14
IRI, U/ml 5  4 12  8† 12
HOMA-IR 1.1  0.7 3.4  3.0 4.2
Blood lipid levels, mg/dl
Total cholesterol 191  32 190  42 19
Triglycerides 137  63 147  90 15
HDL cholesterol 48  10 46  15 4
LDL cholesterol 116  28 119  33 12
C-reactive protein, mg/l 2.7  4.3 4.3  8.5 3.
Medication
Aspirin 34 (90) 42 (96) 7
Ticlopidine 23 (61) 31 (71) 5
Statins 21 (55) 21 (48) 3
ACE-I/ARB 18 (47) 21 (48) 3
Nitrates 33 (87) 43 (98) 7
Calcium-channel blockers 18 (47) 13 (30) 3
Beta-blockers 21 (55) 24 (55) 3
Insulin 0 (0) 0 (0) 1
p  analysis of variance; p values for fasting blood sugar, IRI, HOMA-IR, and
adjusted. Values are mean  standard deviation or number of patients (percent
†p  0.01 (vs. NGR); ‡p  0.0001 (vs. NGR and IGR); §p  0.001 (vs. NGR); p 
ACE-I  angiotensin-converting enzyme inhibitor; ARB  angiotensin II type 1
 diabetes mellitus; HDL high-density lipoprotein; HOMA-IR homeostasis m
resistance; IGR impaired glucose regulation; IRI  immunoreactive insulin; LDDM
 83) p Value
6 (68) 0.39
9  9 0.86
5 (66) 0.96
4 (29) 0.76
9 (23) 0.71
8 (34)* 0.06
2 (63) 0.33
6  12 0.58
6  51‡ 0.0001
 12§ 0.002
 3.7‡ 0.0001
8  35 0.46
4  95 0.61
6  12 0.68
1  29 0.71
7  7.0 0.61
8 (94) 0.53
3 (64) 0.63
5 (42) 0.41
9 (47) 0.99
6 (92) 0.29
3 (40) 0.25
4 (41) 0.20
4 (17)§ 0.0004
insulin were Bonferroni
age). *p  0.05 (vs. NGR);
0.005 (vs. NGR).
receptor antagonist; DM
odel assessment of insulin
L  low-density lipopro-tein; NGR  normal glucose regulation.
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420.2 at univariate analysis and other confounding
ariables were considered in the model. A p value
0.05 was considered statistically significant.
E S U L T S
tudy populations and baseline characteristics. An
VUS was performed on 172 consecutive patients
uring the study period. Seven patients (3 patients
ith DM, 2 patients with IGR, and 2 patients with
GR) were excluded because the IVUS catheter
ould not cross or IB-IVUS data were not avail-
ble. Finally, conventional and IB-IVUS analyses
ere completed on 165 patients: 83 in the DM
roup, 44 in the IGR group, and 38 in the NGR
roup. There were no significant clinical differences
mong the 3 groups except for glucometabolic
arameters (Table 1).
uantitative parameters of conventional and IB-
VUS. Table 2 shows the conventional IVUS findings.
n the 2D analysis, there were no significant differ-
nces in various parameters among the 3 groups. The
D analysis indicated that plaque volume per lesion
ength (p 0.02) and percentage of plaque volume (p
0.002) were significantly increased in the DM
roup compared with the other 2 groups. In the
B-IVUS analysis, as compared with the NGT group,
he DM group and the IGR group showed a signif-
cant increase in %LV (36  14% and 37  13% vs.
9  14%, p  0.02) (Fig. 1A) and a significant
ecrease in %FV (59  11% and 58  11% vs. 64 
1%, p  0.03) (Fig. 1B). There were no significant
ifferences in high signal volume among the 3 groups
Fig. 1C). On logistic regression analysis after adjust-
ng for confounding (age, gender, and body mass
ndex) and coronary (incidence of ACS, prevalence of
ata for Conventional Intravascular Ultrasound
NGR
(n  38)
IGR
(n  44)
DM
(n  83)
p
Value
, mm2 10.8 4.1 11.3 3.8 11.6 3.9 0.36
a, mm2 3.6 2.1 3.8 2.6 3.4 1.9 0.61
a, mm2 7.2 3.7 7.5 3.0 8.2 3.6 0.15
den, % 65 15 66 16 69 15 0.10
y index 0.58 0.07 0.58 0.08 0.60 0.08 0.20
g index 0.96 0.20 1.00 0.17 0.97 0.20 0.52
me, mm3/mm 11.9 4.5 11.8 3.9 12.2 4.4 0.69
ume, mm3/mm 5.6 2.5 5.6 2.6 5.2 2.4 0.39
ume, mm3/mm 6.1 2.9 6.1 2.3 6.9 2.9* 0.02
que volume, % 51 12 53 12 57 17†,‡ 0.002
s of variance; p values for plaque volume and percent plaque volume were
djusted. Values are mean  standard deviation. *p  0.05 (vs. NGR and IGR); †p
GR); ‡p  0.005 (vs. NGR).
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Figure 1. Comparisons of IB-IVUS Parameters Among the
3 Groups
(A) Percentage of lipid volume (%LV). (B) Percentage of ﬁbrous
volume (%FV). (C) Percentage of high signal volume. Coronary
arteries in patients with impaired glucose resistance (IGR) and
diabetes mellitus (DM) signiﬁcantly increased in %LV (37  13%
and 36  14% vs. 29  14%, p  0.02) and signiﬁcantly
decreased in %FV (58  11% and 59  11% vs. 64  11%, p 
0.03) compared with those with normal glucose regulation
(NGR). ANOVA  analysis of variance; IB-IVUS  integratedTable 2. D
Vessel area
Lumen are
Plaque are
Plaque bur
Eccentricit
Remodelin
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43ypertension, smoking status, elevated C-reactive pro-
ein, and use of statin and insulin) risk factors, the
M group (odds ratio 3.52, 95% confidence interval
.13 to 11.0, p 0.03) and the IGR group (odds ratio
.92, 95% confidence interval 1.13 to 13.6, p  0.03)
ere significantly associated with the lipid-rich plaque
Table 3). The lipid-rich plaque rate was significantly
ssociated with an increasing HOMA-IR in the
ertile (p  0.008) (Fig. 2). Figure 3 shows the
epresentative images of conventional and 2D IB-
VUS color-coded maps of coronary lesions with the
owest (Fig. 3A) or the highest (Fig. 3B) tertile of
OMA-IR. The %LA and %FA were 30% and 68%
n Figure 3A and 46% and 49% in Figure 3B,
espectively. The correlation of %LV and %FV mea-
ured by 2 physicians who conducted IVUS measure-
ent independently was r 0.91 (p 0.01) and r
.92 (p  0.01), respectively.
I S C U S S I O N
he main finding of this study is that IGR as well
s DM is significantly associated with an increase in
LV and a decrease in %FV and that the preva-
ence of IGR and DM are independent predictors
or lipid-rich plaque. Furthermore, the highest
ertile of HOMA-IR (3.4) had significantly in-
reased lipid-rich plaque rates.
Although DM is well known to be a major CVD
isk factor (19), the increased risk for CVD is
pparent already at a pre-diabetic state (4,20), and
CS significantly affects mortality, morbidity, and
uality of life in these patients. It has been reported
hat disruption or erosion of vulnerable plaques and
ubsequent thrombus are the most frequent causes
f ACS (21,22) and that coronary plaque instability
s mainly relevant to the lipid-rich plaque (13–15).
n the present study, lipid-rich plaque defined as an
ncrease in %LV and a decrease in %FV was
ignificantly associated with the prevalence of ACS,
onsistent with previous reports showing the rela-
ionship between ACS and lipid-rich plaque (13–
5). Furthermore, even after adjusting for the con-
ounding and pre-defined variables, DM and IGR
ere independently associated with lipid-rich
laque. These results suggest that patients with
GR might have lipid-rich plaque, resulting in the
evelopment of adverse cardiac events.
Insulin resistance progressively increases when
assing from NGR through IGR to DM (23). Im-
aired glucose regulation will develop only when
nsulin secretion fails to compensate fully for IR (24),
esulting in postprandial hyperglycemia. Such a mech-nism could be sufficient to contribute to progression
f atherosclerosis even in the IGR phase (25). In the
resent study, IR defined as HOMA-IR was signifi-
antly increased in patients with IGR and DM com-
ared with those with NGR. Furthermore, the lipid-
ich plaque rates were significantly associated with an
ncreasing tertile of HOMA-IR. Metabolic syndrome
s chiefly based on IR and the cluster of comorbidities
f AGR. In light of the present results, IR might be a
rimary contributor to our previous findings showing
he association between metabolic syndrome and
ipid-rich plaque (13).
The lipid-rich plaque defined in the present
tudy might not be considered a predominant
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Figure 2. The Lipid-Rich Plaque Rate According to the Tertile
of HOMA-IR
Insulin resistance (IR) was deﬁned from the homeostasis model
assessment of insulin resistance (HOMA-IR). The cutoff point for
the lipid-rich plaque was deﬁned as percentage of lipid volume
(%LV) 44% or percentage of ﬁbrous volume (%FV) 52%,
which was the 75th percentile of %LV or the 25th percentile of
%FV in this study population. The lipid-rich plaque rate was sig-
niﬁcantly associated with an increasing tertile of HOMA-IR (p 
0.008 by analysis of variance [ANOVA]). These results suggest
Table 3. Logistic Regression Model for Prediction of
Lipid-Rich Plaque
Variable
Odds
Ratio
95%
Conﬁdence
Interval
p
Value
Abnormal glucose regulation 3.65 1.25–10.7 0.02
Diabetes mellitus 3.52 1.13–11.0 0.03
Impaired glucose regulation 3.92 1.13–13.6 0.03
Acute coronary syndrome 2.35 1.02–5.39 0.04
Hypertension 2.09 0.86–5.09 0.10
C-reactive protein (3 mg/l) 1.33 0.59–2.98 0.50
Smoking 1.13 0.48–2.65 0.79
Adjusted for confounding factors (age, gender, and body mass index) and use
of insulin and statin. Each listed variable was adjusted for all other variables.the relationship between IR and greater lipid-rich plaque content.
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44arker of plaque instability. With a slightly differ-
nt methodology (virtual histology and IVUS ra-
iofrequency analysis), another Japanese group (26)
ecently showed that the amount of lipid content
as not higher and the amount of fibrotic tissue was
ot lower in patients with ACS compared with
table patients. Although this report provides im-
ortant insight into ruptured plaques, it focused on
Figure 3. Representative Images of Conventional and 2D
IB-IVUS Color-Coded Maps of Coronary Artery Plaques
The percentage of lipid area (%LA) and the percentage of
ﬁbrous area (%FA) were automatically calculated by IB-IVUS. The
%LA and %FA were (top panels) 30% and 68% in patients with
the lowest tertile of the HOMA-IR, and (bottom panels) 46%
and 49% in patients with the highest tertile of HOMA-IR. Blue 
lipid pool; green/yellow  ﬁbrous lesion; red  high signal
lesion. 2D  2-dimensional; other abbreviations as in Figures 1
and 2.MJ, et al. A prospective study of Med 2001;161:397he minimal luminal site. There are scant IVUS
ata defining plaque instability before the occur-
ence of rupture. Sano et al. (15) have shown the
orphology of plaque instability before the occur-
ence of ACS. In that study of plaques before ACS
sing IB-IVUS, the %LA was greater in the vul-
erable plaque than in the stable plaque. However,
higher lipid content did not necessarily translate
nto mote vulnerable plaques. Cap thickness (be-
ond the resolution of IB-IVUS) is another major
layer in the field. True plaque instability means an
ctive change from 1 point in time to another,
esulting in plaque rupture. Therefore, a longitudi-
al and prospective study is needed to assess the
recise prognostic value of the lipid-rich plaque in
he development of future coronary events.
tudy limitations. In the present study, although it is
ypothesized that lipid-rich plaques are those con-
ributing to plaque instability, these data were not
xamined. Taken together with other results, larger
tudies should confirm present findings before any
reventive or therapeutic implication could be
uggested.
O N C L U S I O N S
n conclusion, coronary lesions in patients with
GR are associated with lipid-rich plaque, which
ay be related to the increased IR in these patients.
urther study is needed to provide therapeutic
nformation on the need for any intervention to
educe IR even in the IGR state.
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